Bot Detector
IJPC Seal
Download FREE Sample Issue or Article
LEARN MORE
Subscribe Today
A subscription to IJPC includes a print copy delivered by postal mail and on-line access to electronic PDF copies of your subscribed issues.

Compounding for Feline Herpetic Keratitis

Author(s):  Davidson Gigi S

Issue:  Nov/Dec 2006 - Veterinary Compounding
View All Articles in Issue

Page(s):  411-414

Compounding for Feline Herpetic Keratitis Page 1
Compounding for Feline Herpetic Keratitis Page 2
Compounding for Feline Herpetic Keratitis Page 3
Compounding for Feline Herpetic Keratitis Page 4

Download in electronic PDF format for $75

Abstract:  Feline herpetic keratitis (infectious keratoconjunctivitis), an infection of the conjunctiva and cornea that is common in cats, involves a three-pronged treatment approach: (1) antiviral therapy, (2) immunomodulatory therapy, and (3) antibacterial therapy. Since very few agents have been approved for the treatment of feline herpetic keratitis, and many of the drugs that were approved at one time for this indication can no longer be purchased, compounding pharmacists can play a vital role in the prevention and treatment of this infection. Investigators at the Colorado State University College of Veterinary Medicine and Biomedical Sciences evaluated the effect of a new antiviral agent, cidofovir, for ophthalmic use in treating feline herpetic keratitis. Researchers concluded that application of cidofovir significantly decreased the clinical signs of acute ocular infection in cats with feline herpesvirus type 1, one of the primary causes of feline herpetic keratitis. Working with veterinary ophthalmologists, com

Related Keywords: Gigi S Davison, BS, RPh, FSVHP, DICVP, cats, ophthalmic disorders, herpetic keratitis, infectious keratoconjunctivitis, feline herpesvirus type 1, cidofovir, antiviral agent, eye infection, ocular disorders, cornea, conjunctivitis, intraocular administration, formulation, dosage forms, topical preparations

Related Categories: EXCIPIENTS, FORMULATIONS, OPHTHALMICS, VETERINARY, DOSAGE FORMS/DRUG CARRIERS, INFECTIOUS DISEASE

Printer-Friendly Version



Related Articles from IJPC
Title/Author
(Click for Abstract / Details / Purchase)
Issue/​Page
View/Buy
Compounding for Feline Herpetic Keratitis
Davidson Gigi S
Nov/Dec 2006
Pg. 411-414

Feline Ophthalmic Disease: Feline Herpesvirus and Systemic Hypertension
Davidson Michael G
Mar/Apr 2001
Pg. 92-94

Autologous Eye Drops for the Treatment of Dry Eye and Neurotrophic Keratitis
Mixon William
, Angelle Patricea (Patsy), Chang Richard I
Nov/Dec 2009
Pg. 506-515

Diverse Challenges in Pediatric Compounding: Treating Pulmonary Hypertension, Uncombable Hair Syndrome, and Acanthamoeba keratitis
Muller George
, Young Thomas W, Reina Rachel, Caldwell Delmar R
Jan/Feb 2010
Pg. 40-45

Ronidazole in the Treatment of Trichomonad Infections in Cats
Davidson Gigi S
Nov/Dec 2006
Pg. 434-435

Veterinary Ophthalmic Practice: Therapeutic Considerations and Common Ocular Diseases - Part 1
Davidson Gigi S
May/Jun 2004
Pg. 169-172

Veterinary Ophthalmic Practice: Therapeutic Considerations and Common Ocular Diseases - Part 3
Davidson Gigi S
Sep/Oct 2004
Pg. 359-367

Basics of Compounding for Disorders of the External Ear
Allen Loyd V Jr
Jan/Feb 2004
Pg. 46-48

Basics of Sterile Compounding: Ophthalmic Preparations, Part 2: Suspensions and Ointments
Allen Loyd V Jr
Nov/Dec 2016
Pg. 495-500

Feline Urologic Syndrome and Diet Formulation
Long Scott F
Sep/Oct 1999
Pg. 366-367

Unlicensed Transdermal Medications in Feline Patients: Three Case Reports
Urwin Craig
, Jean Linda, Carvalho Maria, Robson-Laws Michael
Nov/Dec 2022
Pg. 468-472

Veterinary Ophthalmic Practice: Therapeutic Considerations and Common Ocular Diseases - Part 2
Davidson Gigi S
Jul/Aug 2004
Pg. 277-283

Physicochemical and Microbiological Stability of Vancomycin 10-mg/mL Intravitreal Syringes
Bartoll Aaron Puplà
, Bellés Medall Maria Dolores, Peñarrocha Josep Edo, Escrig Laura Solaz, Clemente Ruben Eguren, Azuara Julia Bodega, Piqueres Raul Ferrando
Jul/Aug 2022
Pg. 330-335

Wetting and/or Solubilizing Agents, Featured Excipient:
Allen Loyd V Jr
Jul/Aug 2001
Pg. 310-312

I See Colors: Using Vital Dyes in Diagnosing Ophthalmic Disease
McElhiney Linda F
May/Jun 2012
Pg. 190-195

Prednisolone 1 mg/mL in SyrSpend SF pH4
Allen Loyd V Jr
May/Jun 2020
Pg. 229

Drug Therapy for Acute and Chronic Pain in the Cat
Lascelles B Duncan
Sep/Oct 2002
Pg. 338-343

Transdermal Amlodipine Besylate in Lipoderm for the Treatment of Feline Hypertension: A Report of Two Cases
Mixon William
, Helms Scott R
Sep/Oct 2008
Pg. 392-397

Prednisolone Sodium Phosphate 1.4 mg/mL in SyrSpend SR pH4, Cherry Flavored
Allen Loyd V Jr
Nov/Dec 2019
Pg. 487

Compounding for Treatment of Equine Infectious Diseases: An Overview
Bramwell Bethany L
Nov/Dec 2011
Pg. 450-457

Return to Top